Non-Steroidal Anabolics: Kynoselen is an injectable mixture of heptaminol, adenosine monophosphate, B-12, selenium, magnesium, and potassium. It is used in animals to speed healing form injury and improve athletic performance (although it is banned from use in horse and dog racing), which attracts many speed and strength athletes to its use. Kynoselen also has anabolic (muscle building) and lipolytic (fat burning) properties despite it being non-steroidal. (1)
Athletes are attracted to Kynoselen because heptaminol, the main active ingredient, has been shown to improve contractile strength of muscle tissue and minimize fatigue. (1, 2) The anabolic effects of Kynoselen likely come from the ability of heptaminol to increase the differentiation of satellite muscle cells, which can lead to the building of skeletal muscle. (1, 3) Kynoselen is also a mild stimulant, because it blocks the re-uptake and stimulates the release of norepinephrine. (4) This effect may explain the lipolytic properties of Kynoselen. (1) The fact that Kynoselen is non-steroidal makes it attractive to women who are looking to build muscle without the masculinizing side effects of other anabolic substances. Kynoselen also may be useful during post-cycle therapy due to its non-hormonal anabolic effects.
Kynoselen appears to be light in terms of side effects. The main side effects are those that are typical of stimulants such as rapid heartbeat and dizziness if the dosage is taken too high. Kynoselen is also 100% legal, making it relatively easy to obtain. (1)
1. Llewellyn, W (2006). Anabolics 2006. Jupiter, FL: Body of Science
2. Allard B, Jacquemond V, Lemtiri-Chlieh F, Pourrias B, & Rougier O. (1991). Action of heptaminol hydrochloride on contractile properties in frog isolated twitch muscle fibre. British Journal of Pharmacology. 104(3), 714-8.
3. Pourrias B. (1991). Le chlorhydrate d’heptaminol: nouvelles données. Annales Pharmaceutiques Françaises. 49(3), 127-38.
4. Grobecker H. (1970). On the mode of action of heptaminol. Naunyn-Schmiedebergs Archiv Für Pharmakologie. 266(4), 339-40.